Safety and Efficacy Evaluation of CD19-UCART
NCT03229876
·
clinicaltrials.gov ↗
NA
Phase
SUSPENDED
Status
20
Enrollment
INDUSTRY
Sponsor class
Stopped
Sponsor decision
Conditions
Acute Lymphoblastic Leukemia (ALL)
Non Hodgkin Lymphoma (NHL)
Interventions
BIOLOGICAL:
CD19-UCART
Sponsor
Bioray Laboratories
Collaborators
[object Object]
[object Object]
[object Object]